178 related articles for article (PubMed ID: 37812361)
1. The Combination of Citicoline and Nicotinamide Mononucleotide Induces Neurite Outgrowth and Mitigates Vascular Cognitive Impairment via SIRT1/CREB Pathway.
Zhao N; Zhu X; Xie L; Guan X; Tang L; Jiang G; Pang T
Cell Mol Neurobiol; 2023 Nov; 43(8):4261-4277. PubMed ID: 37812361
[TBL] [Abstract][Full Text] [Related]
2. Metformin, Rapamycin, or Nicotinamide Mononucleotide Pretreatment Attenuate Cognitive Impairment After Cerebral Hypoperfusion by Inhibiting Microglial Phagocytosis.
Yu M; Zheng X; Cheng F; Shao B; Zhuge Q; Jin K
Front Neurol; 2022; 13():903565. PubMed ID: 35769369
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons.
Chandrasekaran K; Choi J; Arvas MI; Salimian M; Singh S; Xu S; Gullapalli RP; Kristian T; Russell JW
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466541
[TBL] [Abstract][Full Text] [Related]
4. β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice.
Li HR; Liu Q; Zhu CL; Sun XY; Sun CY; Yu CM; Li P; Deng XM; Wang JF
Redox Biol; 2023 Jul; 63():102745. PubMed ID: 37201414
[TBL] [Abstract][Full Text] [Related]
5. NAD
Zhao Y; Zhang J; Zheng Y; Zhang Y; Zhang XJ; Wang H; Du Y; Guan J; Wang X; Fu J
J Neuroinflammation; 2021 Sep; 18(1):207. PubMed ID: 34530866
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
Wang X; Hu X; Yang Y; Takata T; Sakurai T
Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide mononucleotide pretreatment improves long-term isoflurane anesthesia-induced cognitive impairment in mice.
Xu J; Chen X; Liu S; Wei Z; Xu M; Jiang L; Han X; Peng L; Gu X; Xia T
Behav Brain Res; 2024 Feb; 458():114738. PubMed ID: 37931707
[TBL] [Abstract][Full Text] [Related]
8. 3‑N‑Butyphthalide improves learning and memory in rats with vascular cognitive impairment by activating the SIRT1/BDNF pathway.
Tian A; Li W; Zai Q; Li H; Zhang RW
Mol Med Rep; 2020 Jul; 22(1):525-533. PubMed ID: 32377741
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Artemisia annua Linné in improving cognitive impairment in a chronic cerebral hypoperfusion-induced vascular dementia animal model.
Kim SY; Kim YJ; Cho SY; Lee HG; Kwon S; Park SU; Jung WS; Moon SK; Park JM; Cho KH; Ko CN
Phytomedicine; 2023 Apr; 112():154683. PubMed ID: 36738479
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects.
Kiss T; Nyúl-Tóth Á; Balasubramanian P; Tarantini S; Ahire C; Yabluchanskiy A; Csipo T; Farkas E; Wren JD; Garman L; Csiszar A; Ungvari Z
Geroscience; 2020 Apr; 42(2):527-546. PubMed ID: 32056076
[TBL] [Abstract][Full Text] [Related]
11. Combined citicoline and docosahexaenoic acid treatment improves cognitive dysfunction following transient brain ischemia.
Nakazaki E; Yabuki Y; Izumi H; Shinoda Y; Watanabe F; Hishida Y; Kamimura A; Fukunaga K
J Pharmacol Sci; 2019 Apr; 139(4):319-324. PubMed ID: 30871872
[TBL] [Abstract][Full Text] [Related]
12. Hyperforin ameliorates neuroinflammation and white matter lesions by regulating microglial VEGFR
Gao X; Chen J; Yin G; Liu Y; Gu Z; Sun R; Sun X; Jiao X; Wang L; Wang N; Zhang Y; Kan Y; Bi X; Du B
CNS Neurosci Ther; 2024 Mar; 30(3):e14666. PubMed ID: 38468126
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide mononucleotide inhibits oxidative stress-induced damage in a SIRT1/NQO-1-dependent manner.
Nakajo T; Kitajima N; Katayoshi T; Tsuji-Naito K
Toxicol In Vitro; 2023 Dec; 93():105683. PubMed ID: 37640247
[TBL] [Abstract][Full Text] [Related]
14. Shengyu Decoction treating vascular cognitive impairment by promoting AKT/HIF-1α/VEGF related cerebrovascular generation and ameliorating MAPK/NF-κB mediated neuroinflammation.
Fang C; Liu J; Feng M; Jia Z; Li Y; Dai Y; Zhu M; Huang B; Liu L; Wei Z; Wang X; Xiao H
J Ethnopharmacol; 2022 Oct; 296():115441. PubMed ID: 35700854
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects.
Yamane T; Imai M; Bamba T; Uchiyama S
Clin Nutr ESPEN; 2023 Aug; 56():83-86. PubMed ID: 37344088
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
Nadeeshani H; Li J; Ying T; Zhang B; Lu J
J Adv Res; 2022 Mar; 37():267-278. PubMed ID: 35499054
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide mononucleotide (NMN) ameliorated Nonylphenol-induced learning and memory impairment in rats via the central 5-HT system and the NAD
Huang H; Shi J; Li Z; Rang Y; Li W; Xiao X; Chen C; Liu C
Food Chem Toxicol; 2023 Aug; 178():113878. PubMed ID: 37295765
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide mononucleotide administration after sever hypoglycemia improves neuronal survival and cognitive function in rats.
Wang X; Hu X; Zhang L; Xu X; Sakurai T
Brain Res Bull; 2020 Jul; 160():98-106. PubMed ID: 32380185
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide mononucleotide promotes pancreatic islet function through the SIRT1 pathway in mice after severe burns.
Liu X; Li D; Liu Z; Song Y; Zhang B; Zang Y; Zhang W; Niu Y; Shen C
Burns; 2022 Dec; 48(8):1922-1932. PubMed ID: 35123833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
